Products
ABECMA® (idecabtagene vicleucel) Abraxane® (paclitaxel formulated as albumin bound nanoparticles)  Adcortyl® (tramcinolone acetonide) Information Azactam® (aztreonam) Baraclude® (entecavir monohydrate) Camzyos® (Mavacamten) Eliquis® (apixaban) Information Empliciti® (elotuzumab) Information Imnovid® (pomalidomide) Inrebic® (fedratinib dihydrochloride monohydrate) Kenalog® (triamcinolone acetonide) Nulojix® (belatacept) Information Onureg®(azacitidine) Opdivo® (nivolumab) Information Opdualag® (relatlimab/nivolumab) Orencia® (abatacept) Information Revlimid® (lenalidomide) Sotyktu® (deucravacitinib) Sprycel® (dasatinib) Information Thalidomide Information Vidaza® (azacitidine) Information Yervoy® (ipilimumab) Information Zeposia® (ozanimod) Information
Regimen
Opdivo®(nivolumab) + Yervoy® (ipilimumab)

ABRAXANE, AZACTAM, BARACLUDE, CAMZYOS, ELIQUIS, EMPLICITI, EVOTAZ, IMNOVID, INREBIC, KENALOG, NULOJIX, OPDIVO, OPDUALAG, ORENCIA,REVLIMID,  SOTYKTU, SPRYCEL, THALOMID, VIDAZA, YERVOY, ZEPOSIA are trademarks of Bristol-Myers Squibb Company.


References